English 
Español 
Commandments to celebrate the New Year in peace and without burns
Written by Evelyn Alas
The Fondo Solidario Para la Salud (FOSALUD), recommends that if you are one of those who think that celebrating New Year's Eve without gunpowder is not a celebration, you should change the 'chip' of that thought: December after december, the numbers reaffirm that it is not a good idea to handle these explosives and much less allow your children to do so.
Moderna receives FDA clearance for emergency use of Covid-19 booster vaccine
Written by Evelyn Alas
Moderna, Inc., a biotechnology company pioneering messenger ARN (ARNm), therapeutics and vaccines, received emergency use authorization (EUA) from the Food and Drug Administration (FDA) for its bivalent Covid-19 mRNA-1273.222 booster vaccine intended to protect against BA.4/BA.5 variant omicron in children aged 6 months to 5 years.
Mastercard presents LAC Innovation Forum 2022
Written by Evelyn Alas
New technologies such as the metaverse, blockchain and artificial intelligence are transforming the way we interact and understand the future of money and security. To discuss how innovation is driving the new economy, Mastercard is hosting the 11th edition of the Mastercard Latin America and Caribbean Innovation Forum starting tuesday, november 29 and running through wednesday, november 30.
Young women leading a startup in Latin America are 19 to 25 years old
Written by Evelyn Alas
The path of women entrepreneurs in Latin America is not an easy one, but in 2022 we are beginning to see results of the efforts of different organizations, funds and women entrepreneurs who have supported startups led by women. Data that demonstrates this can be found in the Report on women leaders of startups in Latin America: in what sectors they undertake and under what circumstances, prepared by Platzi, the largest Spanish-speaking professional education platform.
Reinforcing the importance of Covid-19 vaccination in children
Written by Evelyn Alas
Representatives of the Asociación de Pediatría de El Salvador (ASOPEDES) held a congress in which they addressed topics of interest, such as the importance of vaccination as a strategy to prevent bacterial resistance, lessons learned from the vaccination against Covid 19 and the effect of long covid in children, regarding what is happening at the moment.
Uber redoubles its commitment to road safety in El Salvador
Written by Evelyn Alas
As part of the Moves event, a project of the Asociación Ohana503 that seeks to save lives on roads, educating and raising awareness about the importance of mobility and road safety, the Uber app reiterated its commitment to promoting safer streets, with the implementation of two new features that will soon be available in El Salvador: users will receive an alert when they have to get out of the vehicle near a bike lane and will seek to prevent distractions for delivery partners on bicycles when making a delivery.
Great Place to Work recognizes Millicom as one of Fortune's Best Places to Work in 2022
Written by Evelyn Alas
Millicom, the leading provider of fixed and mobile telecommunications services in Latin America through its TIGO brand, has been recognized with the fifth position among the Best Places to Work in 2022. The list by Great Place to Work and Fortune magazine ranks the 25 best places to work worldwide.
More than 120 women graduate as electrician technicians
Written by Evelyn Alas
AES El Salvador, through its program "AES Mujer" and the Ministerio de Desarrollo Local, through "Ciudad Mujer" graduated the 2022 class of women electricians. They are 124 new certified technicians from the course "Fourth Category Residential Electrical Installations" and specialized in "Load Reading and Census".
Moderna receives FDA clearance for emergency use of booster vaccine
Written by Evelyn Alas
Moderna, Inc, a biotechnology company pioneering messenger ARN (ARNm), therapeutics and vaccines, announced today that it received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its bivalent COVID-19 booster vaccine targeting omicron BA.4/BA, 5, mRNA-1273.222, for children and adolescents 6 to 17 years of age.